Market Scenario:
Genetic testing has gained popularity over the last few years for detection and prevention of genetic diseases, cancer, etc. The increasing awareness among the population regarding early diagnosis coupled with rising expenditure on preventive measures has fueled demand in the market. It is likely to continue favoring the genetic testing market over the next couple of years.
The technological advancements introduced in the genetic testing market that offers enhanced efficiency and accuracy is expected to fuel demand during the projection period. Adoption of non-invasive genetic testing technology is projected to accelerate revenue creation for market players across the review period.
The Global Genetic testing market is growing moderately. It is growing at the CAGR of ~9.8% during the forecast period. The global genetic testing market expected to reach USD 10,033.4 million by 2023 from USD 4,683 in 2016.
Key Players
- Abbott Laboratories (US)
- Bio-Rad Laboratories, Inc. (US)
- Illumina Inc. (US)
- Myriad Genetics (US)
- PerkinElmer Inc. (US)
- QIAGEN N.V. (Germany)
- Quest Diagnostics (US)
Genetic testing involves the use of laboratory methods to study the genes inherited from mother or father. These tests may be used to identify increased risks of health problems, to diagnose the mutations in the genes, to choose treatments, or to assess responses to treatment.
Segments:
Global genetic testing market has been segmented on the basis of type which prescribed genetic testing, and direct to consumer (DTC) genetic testing. Prescribed Genetic Testing accounted for the largest market share in 2016. On the basis of method, it is segmented into Molecular Genetic Test/ DNA Test, Chromosomal Genetic Test, Biochemical Genetic Test. Molecular Genetic tests/DNA was holding largest market share in 2016. On the basis of type of test, the market is segmented into Diagnostic Test, Predictive Test, Family DNA Test, and others. Diagnostic test accounted for the largest market share in 2016. On the basis of indication it is segmented into Cancer Testing, Neurogenetic Disorder Testing, Autoimmune Disorder Testing, Muscular dystrophies, and others. Cancer Testing accounted for the largest market share in 2016.
Regional Analysis
Regional Analysis
By region, the global genetic testing market has been segmented into America, Europe, Asia Pacific, and the Middle East & Africa. America held the largest share of the market in 2016 which accounted for 46.3% share. It is likely to retain a significant share towards the end of the forecast period. The growth in the region is attributable to the accelerated adoption of technology, increasing awareness about genetic testing, continuous innovation, etc. Europe is a significant growth pocket in the genetic testing market. The regional market is estimated to reach a valuation of USD 2,553.10 Mn by the end of 2023. Asia Pacific is projected to exhibit the steepest rise in market proliferation striking a CAGR of 10.1% through the assessment period. However, the Middle East & Africa region is poised to stage restricted growth due to lack of infrastructure and limited awareness.
Browse Complete 140 Pages Premium Research Report Enabled with 174 Respective Tables and Figures at @ https://www.marketresearchfuture.com/reports/genetic-testing-market-2009
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
No comments:
Post a Comment